Trial intelligence / Profile preview

Prospective randomized phase II study evaluating dasatinib dosing in de novo chronic phase CML

2008-006854-17Phase 2Completed

Sponsor

Centre Hospitalier de Versailles

Start

Mar 2009

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1